Terms of Use
These terms of use are binding for Biotechgate, its distribution partners and all related portals (see paragraph 2).
1. Preface
By using Biotechgate (including searching the database, visiting profiles, adding / updating information as well as submitting any information to the portal) or a related portal (see below “Party to the Contract”) you agree to these Terms of Use.
2. Party to the Contract
The Biotechgate Business Development Database (Biotechgate) is property of and managed by Venture Valuation VV AG (Venture Valuation), Zurich, Switzerland. Database subscription agreements are made between the subscriber and Venture Valuation. These Terms of Use are also binding for all portals related to Biotechgate and for all of Biotechgate’s distribution partners (such as Lingmed Limited or any portal mentioned at https://www.biotechgate.com/countries). Therefore, in the following Terms of Use the expression “Biotechgate” includes the Biotechgate Database as well as all related portals.
3. Publishing of company profiles
Adding and updating company profiles to Biotechgate is completely free of charge. Venture Valuation reserves the right to exclude or otherwise edit any information submitted to its databases. Relevant changes to the profiles, which were made by a company employee or authorized person in connection with the corresponding profile will be reviewed by Venture Valuation prior to activation.
4. Extent of Available Information
The amount of profiles and additional information available on our website may vary from day to day. We do our best to increase the extent of the available information and its accuracy. Each profile can be updated by the organization itself. Venture Valuation then checks relevant changes of the data before publishing it. However, we do not guarantee a minimum number of available company profiles, nor the completeness or accuracy of any profile published in the database. Venture Valuation cannot be held liable for any information available or missing from the database.
5. Quality of available information
Venture Valuation assumes no liability for any damage or loss arising from access to or use of the Biotechgate website, the database, and the information contained therein.
The Biotechgate Database and all the data included in the database is free of any infringement of any third parties’ rights and/or breaches of Biotechgate obligation under other agreements.
6. Use of information
As a user you agree that any downloaded content will be used for internal purposes only. Particularly, data harvesting will not be allowed, nor the unreasonable use of contact details in sending out emails. Furthermore, no data can be made available to third parties. No part of this website may be reproduced or transmitted in any form or by any means, electronically, mechanically, by photocopying, by recording or otherwise, without prior permission from Venture Valuation. All data must be deleted if your subscription to this data ends.
7. Extent of use
Unless otherwise specified Biotechgate subscriptions are not restricted in terms of the amount of data, but are intended for reasonable usage. The “unlimited” access a subscriber gets to the database does not constitute the right to systematically download all available information in the database. Venture Valuation has the right to block or cancel an account if Venture Valuations deems that a subscriber has exceeded the limit of normal usage (especially if it can be inferred that a subscriber is collecting e-mail addresses). Any use of automated data collecting software is strictly prohibited.
8. Subscriptions & Pricing
Unless otherwise stated in the proposal or contract, the prices for subscriptions are valid for one (1) license per person for the corresponding time period (see also “Renewal” below). All terms described in this document also apply for site licenses (multiple users). Special rates are available for small and mid-size companies. Please contact us for more details (see below “Contact information”).
Prices of multi-year contracts are fixed over the agreed contract period. For other contracts without fixed terms of several years, we keep the right to vary or increase the prices of the subscriptions. Price increases for automatic recurring payments will be announced by e-mail at least one month prior to the renewal of the subscription. If a subscriber does not agree on the new pricing, the subscription can be cancelled according to the terms described under “Cancellation of Subscription”.
9. Renewal
Unless otherwise agreed, your subscription will not be automatically renewed. You will usually be contacted by a Sales Representative a few weeks before the subscription expires to seamlessly renew your subscription. If you have a multi-year contract, the subscription will automatically renew during the term and we will send you an invoice with the specified amount or your credit card will be charged. If you pay by credit card, you will receive an email with a link to the payment receipt. A receipt can also be downloaded at any time in your account under “Subscriptions”.
10. Cancellation of Subscription
Unless otherwise stated in the proposal or contract, subscriptions with automatic renewal can be cancelled up to two days before the current subscription period ends. You can cancel your subscription either in your account in the section “Subscriptions” or by sending us an e-mail (see “Contact information” below). If you cancel it later, the subscription fee for one more period will be charged to your credit card. If you cancel a recurring subscription, the subscription remains active until the end of the period for which the last payment has been made. If you cancel a subscription by e-mail, you will receive an e-mail notification once the subscription has been cancelled. If you do not receive such a notification within two working days after cancellation, it must be assumed that we did not receive the e-mail. In this case please contact us again.
11. Refund of payments
Venture Valuation does not refund any payments after cancellation of the subscription. If a subscription is cancelled, no further payments will be charged in the future.
12. Expired Subscriptions
If a subscription expires, the account is still available to the user for at least one year after the date of expiration to access notes but the extent of information and features will be limited.
13. Use of subscriber’s company for reference purposes
Unless otherwise specified in the proposal or contract or agreed upon with the Sales Representative by e-mail, Venture Valuation has the right to use the company name and logo of users as a reference on its websites, in email marketing campaigns, on printed materials or in social media. If a client does not agree to this, the client must inform Venture Valuation in writing. Venture Valuation will then remove the logo and company name from all its websites within 14 days and will not use them in any future campaigns and printed material.
14. Limitation of Liability
In no event shall Venture Valuation VV AG be liable for damages resulting from loss of data or use of the Biotechgate Database, or for any incidental, indirect, punitive, or consequential damages in connection with this agreement or in connection with any products or services provided. We shall exert our best effort to provide you with the highest availability of Database services. We are, however, dependent on external parties and cannot provide any guarantee as to availability or accuracy. We reserve the right to change external parties and information providers at any time.
15. Copyright
All content on Biotechgate and its related portals, including text, graphics, logos, icons, images, audio clips, video clips, digital downloads, data compilations, and software, is the property of Venture Valuation or its content suppliers and protected by international copyright laws. The compilation of all content on this site is the exclusive property of Venture Valuation and protected by international copyright laws. All software used on this site is the property of Venture Valuation or its software suppliers and protected by international copyright laws.
16. License and Site Access
Venture Valuation grants you a limited license to access and make personal use of this site but not to download (other than page caching) or modify it, or any portion of it, except with express written consent of Venture Valuation. This site or any portion of this site may not be reproduced, duplicated, copied, sold, resold, visited, or otherwise exploited for any commercial purpose without express written consent from Venture Valuation. This license does not include any resale or commercial use of this site or its contents or any derivative use of this site or its contents.
17. Applicable Law
By visiting Biotechgate or a related portal, you agree that the laws of Switzerland, without regard to principles of conflict of laws, will govern these Conditions of Use and any dispute of any sort that might arise between you and Venture Valuation or its affiliates.
18. Site Policies, Modification, and Severability
Venture Valuation reserves the right to make changes to our site, policies, and these Terms of Use at any time. If any of these conditions shall be deemed invalid, void, or for any reason unenforceable, that condition shall be deemed severable and shall not affect the validity and enforceability of any remaining conditions.
19. Changes to Terms of Use
If Venture Valuation decides or needs to change these Terms of Use, it will post those changes in this Terms of Use and other places we deem appropriate. Venture Valuation reserves the right to revise, amend, or modify these Terms of Use, and any of our other policies and agreements at any time and in any manner, so please review this document frequently. If we make material changes to these terms, we will notify you here or by means of a notice on our dashboard.
20. Contact information
Biotechgate
c/o Venture Valuation VV AG
Kasernenstrasse 11
CH-8004 Zurich
Switzerland
Phone: +41 (43) 321 86 60
Fax: +41 (43) 321 86 61
E-mail: support@biotechgate.com
www.venturevaluation.com
21. Update history
These Terms of Use were published on September, 5th 2022.